3G1L

EthR from Mycobacterium tuberculosis in complex with compound BDM14744


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.7 Å
  • R-Value Free: 0.278 
  • R-Value Work: 0.231 

wwPDB Validation 3D Report Full Report


This is version 1.2 of the entry. See complete history

Literature

Synthetic EthR inhibitors boost antituberculous activity of ethionamide.

Willand, N.Dirie, B.Carette, X.Bifani, P.Singhal, A.Desroses, M.Leroux, F.Willery, E.Mathys, V.Deprez-Poulain, R.Delcroix, G.Frenois, F.Aumercier, M.Locht, C.Villeret, V.Deprez, B.Baulard, A.R.

(2009) Nat.Med. (N.Y.) 15: 537-544

  • DOI: 10.1038/nm.1950
  • Primary Citation of Related Structures:  
  • Also Cited By: 3QPL

  • PubMed Abstract: 
  • The side effects associated with tuberculosis therapy bring with them the risk of noncompliance and subsequent drug resistance. Increasing the therapeutic index of antituberculosis drugs should thus improve treatment effectiveness. Several antituberc ...

    The side effects associated with tuberculosis therapy bring with them the risk of noncompliance and subsequent drug resistance. Increasing the therapeutic index of antituberculosis drugs should thus improve treatment effectiveness. Several antituberculosis compounds require in situ metabolic activation to become inhibitory. Various thiocarbamide-containing drugs, including ethionamide, are activated by the mycobacterial monooxygenase EthA, the production of which is controlled by the transcriptional repressor EthR. Here we identify drug-like inhibitors of EthR that boost the bioactivation of ethionamide. Compounds designed and screened for their capacity to inhibit EthR-DNA interaction were co-crystallized with EthR. We exploited the three-dimensional structures of the complexes for the synthesis of improved analogs that boosted the ethionamide potency in culture more than tenfold. In Mycobacterium tuberculosis-infected mice, one of these analogs, BDM31343, enabled a substantially reduced dose of ethionamide to lessen the mycobacterial load as efficiently as the conventional higher-dose treatment. This provides proof of concept that inhibiting EthR improves the therapeutic index of thiocarbamide derivatives, which should prompt reconsideration of their use as first-line drugs.


    Related Citations: 
    • Insights into mechanisms of induction and ligands recognition in the transcriptional repressor EthR from Mycobacterium tuberculosis.
      Frenois, F.,Baulard, A.R.,Villeret, V.
      (2006) Tuberculosis 86: 110
    • EthR, a repressor of the TetR/CamR family implicated in ethionamide resistance in mycobacteria, octamerizes cooperatively on its operator.
      Engohang-Ndong, J.,Baillat, D.,Aumercier, M.,Bellefontaine, F.,Besra, G.S.,Locht, C.,Baulard, A.R.
      (2004) Mol.Microbiol. 51: 175
    • Structure of EthR in a ligand bound conformation reveals therapeutic perspectives against tuberculosis.
      Frenois, F.,Engohang-Ndong, J.,Locht, C.,Baulard, A.R.,Villeret, V.
      (2004) Mol.Cell 16: 301


    Organizational Affiliation

    Institut National de la Santé et de la Recherche Médicale, Lille, France.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
TRANSCRIPTIONAL REGULATORY REPRESSOR PROTEIN (TETR-FAMILY) ETHR
A
256Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)Mutation(s): 0 
Gene Names: ethR (etaR)
Find proteins for P9WMC1 (Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv))
Go to UniProtKB:  P9WMC1
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
RF2
Query on RF2

Download SDF File 
Download CCD File 
A
3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole
C14 H10 F N3
KMGPJKOKSYGMJD-UHFFFAOYSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.7 Å
  • R-Value Free: 0.278 
  • R-Value Work: 0.231 
  • Space Group: P 41 21 2
Unit Cell:
Length (Å)Angle (°)
a = 121.738α = 90.00
b = 121.738β = 90.00
c = 33.669γ = 90.00
Software Package:
Software NamePurpose
XDSdata scaling
CCP4phasing
REFMACrefinement
XDSdata reduction
CCP4model building

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Revision History 

  • Version 1.0: 2009-07-21
    Type: Initial release
  • Version 1.1: 2011-07-13
    Type: Version format compliance
  • Version 1.2: 2014-03-12
    Type: Database references